rethinkTHC Search
Menu
Study breakdown

Medical cannabis patients describe it as having fewer side effects than prescriptions but face stigma and dosing confusion

QualitativePreliminary evidence
The takeaway

Medical cannabis cardholders viewed cannabis as having fewer side effects and better quality of life than prescription medications, but cited stigma, cost, and lack of dosing guidance as major barriers.

Medical cannabis patients, prescribers, and policymakers designing medical cannabis programs.

No dosing guidance available

What the researchers found

Three key themes emerged: (1) patients perceived cannabis as having fewer/better side effects and improving quality of life versus prescriptions, (2) patients used cannabis to supplement or replace other medications including opioids, and (3) stigma, travel restrictions, cost, and inability of providers to give dosing/strain guidance significantly limited use.

Why it matters

Patient perspectives reveal practical barriers that surveys miss. The inability of healthcare providers to give dosing guidance leaves patients to experiment on their own, potentially leading to suboptimal or unsafe use.

The numbers in context

25 participants (Rhode Island medical cannabis cardholders); 3 major themes identified; patients specifically mentioned opioid substitution as a primary use case.

How the study worked

Qualitative semi-structured interviews with 25 Rhode Island medical cannabis cardholders, with audio recording, verbatim transcription, and thematic coding.

What this study cannot tell us

Small qualitative sample (25) from one state. Self-selected medical cannabis users may have more positive views. No clinical outcome verification. Rhode Island policies may not generalize.

How to read the evidence

Preliminary: small qualitative study from one state.

When this study was published

Published in 2019.

The bigger picture

The paradox of medical cannabis: patients view it positively and use it as medicine, but the medical system cannot treat it like medicine (no dosing guidance, no strain recommendations, stigma from providers). This gap may limit both safety and efficacy.

Questions still open

  • How can healthcare providers offer meaningful cannabis guidance within current regulatory constraints? Would standardized dosing frameworks improve patient outcomes?

Common questions

Do patients prefer medical cannabis over prescription drugs?
In this study, patients reported cannabis had fewer side effects and better quality of life than prescriptions, and several used it to reduce or replace opioids.
What barriers do medical cannabis patients face?
Key barriers included stigma, cost, inability to travel with cannabis across state lines, and healthcare providers being unable to advise on dosing, strains, or methods of use.

Read the original research

Marijuana as a Substitute for Prescription Medications: A Qualitative Study.

Substance use & misuse, 54(11), 1894-1902

Citation

Mercurio, Alana; Aston, Elizabeth R; Claborn, Kasey R; Waye, Katherine; Rosen, Rochelle K. (2019). Marijuana as a Substitute for Prescription Medications: A Qualitative Study.. Substance use & misuse, 54(11), 1894-1902. https://doi.org/10.1080/10826084.2019.1618336

Explore the wider topic